146 related articles for article (PubMed ID: 33765857)
21. Palliative Prognostic Index Validation in Hospitalized Advanced Cancer Patients in Indonesia Tertiary Hospitals.
Shatri H; Prasetyaningtyas A; Putranto R; Rinaldi I
Acta Med Indones; 2021 Oct; 53(4):442-449. PubMed ID: 35027491
[TBL] [Abstract][Full Text] [Related]
22. Factors Associated With Survival in Patients With End-of-Life Hematological Malignancies Who Received Chemotherapy: A Retrospective Single-Institution Study.
Iizuka-Honma H; Mitsumori T; Yoshikawa S; Takizawa H; Noguchi M
Am J Hosp Palliat Care; 2023 Aug; 40(8):812-819. PubMed ID: 36413462
[TBL] [Abstract][Full Text] [Related]
23. Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study.
Miura T; Matsumoto Y; Hama T; Amano K; Tei Y; Kikuchi A; Suga A; Hisanaga T; Ishihara T; Abe M; Kaneishi K; Kawagoe S; Kuriyama T; Maeda T; Mori I; Nakajima N; Nishi T; Sakurai H; Morita T; Kinoshita H
Support Care Cancer; 2015 Nov; 23(11):3149-56. PubMed ID: 25777319
[TBL] [Abstract][Full Text] [Related]
24. Baseline Neutrophil-to-Lymphocyte Ratio and Glasgow Prognostic Score are Associated with Clinical Outcome in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Treated with Nivolumab.
Chikuie N; Hamamoto T; Ueda T; Taruya T; Kono T; Furuie H; Ishino T; Takeno S
Acta Med Okayama; 2021 Jun; 75(3):335-343. PubMed ID: 34176937
[TBL] [Abstract][Full Text] [Related]
25. A prospective, multicenter cohort study to validate a simple performance status-based survival prediction system for oncologists.
Yamada T; Morita T; Maeda I; Inoue S; Ikenaga M; Matsumoto Y; Baba M; Sekine R; Yamaguchi T; Hirohashi T; Tajima T; Tatara R; Watanabe H; Otani H; Takigawa C; Matsuda Y; Ono S; Ozawa T; Yamamoto R; Shishido H; Yamamoto N
Cancer; 2017 Apr; 123(8):1442-1452. PubMed ID: 27926777
[TBL] [Abstract][Full Text] [Related]
26. A novel nomogram and risk classification system for predicting overall survival in head and neck squamous cell cancer with distant metastasis at initial diagnosis.
Zhu RQ; Zhang YM; Luo XY; Shen WY; Zhu HY
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1467-1478. PubMed ID: 36316576
[TBL] [Abstract][Full Text] [Related]
27. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
[TBL] [Abstract][Full Text] [Related]
28. Predicting the treatment outcome of nivolumab in recurrent or metastatic head and neck squamous cell carcinoma: prognostic value of combined performance status and modified Glasgow prognostic score.
Ueki Y; Takahashi T; Ota H; Shodo R; Yamazaki K; Horii A
Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2341-2347. PubMed ID: 32239313
[TBL] [Abstract][Full Text] [Related]
29. Prognostic models of survival in patients with advanced incurable cancer: the PiPS2 observational study.
Stone P; Kalpakidou A; Todd C; Griffiths J; Keeley V; Spencer K; Buckle P; Finlay DA; Vickerstaff V; Omar RZ
Health Technol Assess; 2021 May; 25(28):1-118. PubMed ID: 34018486
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors for do-not-resuscitate designation among terminally ill cancer patients receiving care from a palliative care consultation service.
Kao CY; Wang HM; Tang SC; Huang KG; Jaing TH; Liu CY; Liu KH; Shen WC; Wu JH; Hung YS; Hsu HC; Chen JS; Liau CT; Lin YC; Su PJ; Hsieh CH; Chou WC
J Pain Symptom Manage; 2014 Feb; 47(2):271-82. PubMed ID: 23856097
[TBL] [Abstract][Full Text] [Related]
31. Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.
Chang PH; Yeh KY; Wang CH; Chen EY; Yang SW; Huang JS; Chou WC; Hsieh JC
Head Neck; 2017 Oct; 39(10):1990-1996. PubMed ID: 28688124
[TBL] [Abstract][Full Text] [Related]
32. Prognostication based on the change in the palliative prognostic index for patients with terminal cancer.
Arai Y; Okajima Y; Kotani K; Tamba K
J Pain Symptom Manage; 2014 Apr; 47(4):742-7. PubMed ID: 23880587
[TBL] [Abstract][Full Text] [Related]
33. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
[TBL] [Abstract][Full Text] [Related]
34. Analysis of palliative care treatment among head and neck patients with cancer: National perspective.
Sullivan CB; Al-Qurayshi Z; Chang K; Pagedar NA
Head Neck; 2021 Mar; 43(3):805-815. PubMed ID: 33151575
[TBL] [Abstract][Full Text] [Related]
35. Development of a predicting tool for survival of terminally ill cancer patients.
Hyodo I; Morita T; Adachi I; Shima Y; Yoshizawa A; Hiraga K
Jpn J Clin Oncol; 2010 May; 40(5):442-8. PubMed ID: 20085908
[TBL] [Abstract][Full Text] [Related]
36. Validation of a Short-Term, Objective, Prognostic Predictive Method for Terminal Cancer Patients in a Palliative Care Unit Using a Combination of Six Laboratory Test Items.
Niki K; Okamoto Y; Matano Y; Ishii R; Matsuda Y; Takagi T; Uejima E
J Palliat Med; 2019 Jun; 22(6):685-690. PubMed ID: 30638435
[No Abstract] [Full Text] [Related]
37. Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation.
Rühle A; Stromberger C; Haehl E; Senger C; David H; Stoian R; Zamboglou C; Knopf A; Budach V; Grosu AL; Nicolay NH
Radiother Oncol; 2021 Jan; 154():276-282. PubMed ID: 33245947
[TBL] [Abstract][Full Text] [Related]
38. Survival of patients with palliative head and neck cancer.
Ledeboer QC; van der Schroeff MP; Pruyn JF; de Boer MF; Baatenburg de Jong RJ; van der Velden LA
Head Neck; 2011 Jul; 33(7):1021-6. PubMed ID: 20967869
[TBL] [Abstract][Full Text] [Related]
39. Prognostic nomograms based on immune scores for head-neck squamous cell carcinoma patients.
Li W; Zhao K; Wang Z
Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2493-2500. PubMed ID: 33068170
[TBL] [Abstract][Full Text] [Related]
40. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
